Global reach MDI Membrane Technologies has sales in more than 50 countries, indicating a broad international footprint and potential for cross-border expansion of filtration products to biopharma and rapid diagnostics markets.

Regulatory readiness ISO 9001:2008 certified manufacturing with some products ISO 13485 certified and a Drug Master File with the US FDA suggests strong quality and regulatory alignment, enabling easier qualification for contracts with pharma, biopharma, and medical device customers.

Custom solutions MDI emphasizes customized, validated filtration products and cost-saving solutions, presenting a clear sales angle for pharma/biopharma customers seeking tailored dead-end filtration and separation capabilities.

Strategic positioning With a 35+ year track record in membranes and competition against major players, there is an opportunity to target mid-market accounts seeking high-quality, cost-effective alternatives to larger suppliers.

Facility and capacity signals A GMP manufacturing facility and a focus on toxicity, biosafety, and extractables align MDIs capabilities with high-integrity projects, suggesting potential for engagement on clinical and manufacturing-scale filtration needs.